Phase I/II Trial for Patients With Recurrent Resectable Glioblastoma Multiforme Using Surgery With Implantable BCNU Polymer Followed by Post-operative Irinotecan and Bevacizumab.
Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 26 Jun 2013
At a glance
- Drugs Bevacizumab; Carmustine; Irinotecan
- Indications Glioblastoma
- Focus Therapeutic Use
- 23 Aug 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 02 Oct 2009 New trial record